Magnetic removal or identification of damaged or compromised cells or cellular structures
US-11662344-B2 · May 30, 2023 · US
US12332239B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12332239-B2 |
| Application number | US-202318139242-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 25, 2023 |
| Priority date | Aug 29, 2012 |
| Publication date | Jun 17, 2025 |
| Grant date | Jun 17, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for magnetic cellular manipulation may include contacting a composition with a biological sample to form a mixture. The composition may include a plurality of particles. Each particle in the plurality of particles may include a magnetic substrate. The magnetic substrate may be characterized by a magnetic susceptibility greater than zero. The composition may also include a chargeable silicon-containing compound. The chargeable silicon-containing compound may coat at least a portion of the magnetic substrate. The biological sample may include cells and/or cellular structures. The method may also include applying a magnetic field to the mixture to manipulate the composition.
Opening claim text (preview).
The invention claimed is: 1. A method for processing, the method comprising: a) contacting sperm cells with a plurality of magnetic particles, the plurality of magnetic particles having an average hydrodynamic diameter of 300 nm and each magnetic particle in the plurality of magnetic particles comprising a negative zeta potential charge and a chargeable silicon-containing compound, the magnetic particles binding to the sperm cells through an electrical charge interaction; and b) applying a magnetic field to the plurality of magnetic particles. 2. The method of claim 1 , wherein each magnetic particle comprises Fe 3 O 4 . 3. The method of claim 1 , wherein the chargeable silicon-containing compound comprises 2-(carbomethoxy)ethyltrimethoxysilane. 4. The method of claim 1 , further comprising the step of diluting the sperm cells with a buffered media prior to step a). 5. The method of claim 1 , wherein each magnetic particle in the plurality of magnetic particles is between 30 nm to 1000 nm in size.
Animal cells · CPC title
Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title
Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction · CPC title
for use in medical or biological applications · CPC title
Magnetic separation whereby the particles are suspended in a liquid · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.